LINC00355 and gastric cancer: In GC, LINC00355 promotes the transcription of RAD18 and UBE3C to mediate the ubiquitination and degradation of p53; this leads to the inhibition of the p53 signaling pathway and promotes the proliferation and invasion of GC cells [16].